Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.

CONCLUSIONS: Use of medications associated with QT prolongation is common in CKD; the safety implications of these findings should be considered in these high-risk patients.
PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2017_08_09_CJASNPodcast_17_09_b.mp3.
PMID: 28793999 [PubMed - as supplied by publisher]

Source: Clinical Journal of the American Society of Nephrology : CJASN - August 9, 2017 Category: Urology & Nephrology Authors: Snitker S, Doerfler RM, Soliman EZ, Deo R, St Peter WL, Kramlik S, Fischer MJ, Navaneethan S, Delafontaine P, Jaar BG, Ojo A, Makos GK, Slaven A, Weir MR, Zhan M, Fink JC, for CRIC Study Investigators Tags: Clin J Am Soc Nephrol Source Type: research